Showing results (371-380 of 907) with videos related to

Sort By:
Pageof 91
Chemotherapy|September 1, 1996
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer centerK V Rolston, L Elting, S Waguespack, et al.
Cancer Treatment Reports|November 1, 1979
Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancerS S Legha, G R Blumenschein, A U Buzdar, et al.
Archives of Internal Medicine|June 1, 1983
Nonbacterial thrombotic endocarditis in a male homosexual with Kaposi's sarcomaI Garcia, V Fainstein, A Rios, et al.
Cancer Treatment Reports|October 1, 1978
Chemotherapy for colorectal cancer with 5-fluorouracil, cyclophosphamide, and CCNU: comparison of oral and continuous iv administration of 5-fluorouracilA Y Bedikian, R Staab, R Livingston, et al.
Cancer Treatment Reports|September 1, 1984
Phase I clinical investigation of homoharringtonineS S Legha, M Keating, S Picket, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Significance of aspergillemia in patients with cancer: a 10-year studyD P Kontoyiannis, D Sumoza, J Tarrand, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 18, 2004
The significance of blood cultures positive for emerging saprophytic moulds in cancer patientsM S Lionakis, G P Bodey, J J Tarrand, et al.
The American Journal of the Medical Sciences|January 1, 1984
A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignanciesR D Lawson, L O Gentry, G P Bodey, et al.
Investigational New Drugs|December 1, 1988
Phase I study of weekly-administered iproplatin [cis-dichloro-trans-dihydroxy-bis-isopropylamine platin (chip, JM9)]S P Chawla, B S Yap, D M Tenney, et al.
American Journal of Clinical Oncology|April 1, 1986
Phase I study of thymidine (dThd) and cisplatin (DDP) given in combinationD F Chiuten, M Valdivieso, J A Benvenuto, et al.
Pageof 91